Title: Lymph protects metastasizing melanoma cells from ferroptosis.

Authors: Ubellacker, Jessalyn M; Tasdogan, Alpaslan; Ramesh, Vijayashree; Shen, Bo; Mitchell, Evann C; Martin-Sandoval, Misty S; Gu, Zhimin; McCormick, Michael L; Durham, Alison B; Spitz, Douglas R; Zhao, Zhiyu; Mathews, Thomas P; Morrison, Sean J

Published In Nature, (2020 09)

Abstract: Cancer cells, including melanoma cells, often metastasize regionally through the lymphatic system before metastasizing systemically through the blood1-4; however, the reason for this is unclear. Here we show that melanoma cells in lymph experience less oxidative stress and form more metastases than melanoma cells in blood. Immunocompromised mice with melanomas derived from patients, and immunocompetent mice with mouse melanomas, had more melanoma cells per microlitre in tumour-draining lymph than in tumour-draining blood. Cells that metastasized through blood, but not those that metastasized through lymph, became dependent on the ferroptosis inhibitor GPX4. Cells that were pretreated with chemical ferroptosis inhibitors formed more metastases than untreated cells after intravenous, but not intralymphatic, injection. We observed multiple differences between lymph fluid and blood plasma that may contribute to decreased oxidative stress and ferroptosis in lymph, including higher levels of glutathione and oleic acid and less free iron in lymph. Oleic acid protected melanoma cells from ferroptosis in an Acsl3-dependent manner and increased their capacity to form metastatic tumours. Melanoma cells from lymph nodes were more resistant to ferroptosis and formed more metastases after intravenous injection than did melanoma cells from subcutaneous tumours. Exposure to the lymphatic environment thus protects melanoma cells from ferroptosis and increases their ability to survive during subsequent metastasis through the blood.

PubMed ID: 32814895

MeSH Terms: No MeSH terms associated with this publication